DEA Nods to Lab's Bid for Controlled Drug Production
Published Date: 7/17/2025
Notice
Summary
Cerilliant Corporation wants to get official permission to make large amounts of certain controlled substances. This affects anyone who works with these drugs, like researchers and medicine makers. If approved, Cerilliant can start producing soon, helping labs get the materials they need without delays or extra costs.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Cerilliant Seeks Bulk Manufacturer Registration
Cerilliant Corporation has applied to be registered as a bulk manufacturer of certain controlled substances. If approved, Cerilliant could produce large quantities of those drugs, which the notice says would help researchers, laboratories, and medicine makers get the materials they need without delays or extra costs.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-10253 — Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
Starting May 22, 2026, the DEA is putting 2-fluorodeschloroketamine (2-FDCK) into Schedule I, meaning it’s now treated like the most dangerous drugs. This affects anyone who makes, sells, or uses it, adding strict rules and serious penalties. The temporary ban lasts two years, giving the government time to decide if it should stay permanent.
2026-10090 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) reviewed and decided on applications for special chemical mixtures that don’t fall under strict drug rules, covering requests from July 2025 to March 2026. Some mixtures got approved, others denied, and a few listings were fixed from earlier notices. If you’re involved with these chemicals, you’ve got until July 20, 2026, to share your thoughts—no fees or big costs involved, just your voice!
2026-09566 — Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Starting May 13, 2026, the DEA officially puts CUMYL-PEGACLONE—a chemical that can be risky—into Schedule I, the strictest drug category. This means anyone making, selling, or using it now faces tough rules and penalties. This move helps the U.S. follow international drug laws and keeps communities safer without any new fees or costs.
2026-08587 — Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.
ANI Pharmaceuticals wants to import certain controlled drugs like Levorphanol and Tapentadol. People who make or use these drugs can share their thoughts or ask for a hearing by June 3, 2026. This move could affect drug availability and regulation, so keep an eye on the deadline to have your say!
2026-08588 — Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Patheon API Inc. wants to make large amounts of special research drugs like dimethyltryptamine and psilocybin. This affects researchers and companies involved in clinical trials, with a chance to comment or ask for a hearing by July 6, 2026. No money changes are mentioned, but this move could speed up important medical studies.
Previous / Next Documents
Previous: 2025-13445 — City of Holyoke Gas & Electric Department; Notice of Effectiveness of Withdrawal of Notices of Intent
The City of Holyoke Gas & Electric got their license extended for the Station No. 5 Hydroelectric Project until 2039, so they’ve officially stopped their plans to reapply right now. This means they won’t need to file new paperwork until 2034, saving time and effort for the next big step. No one objected, and the withdrawal became official on July 11, 2025.
Next: 2025-13447 — South Atlantic Fishery Management Council (Council)-Public Meetings
The South Atlantic Fishery Management Council is hosting two public meetings to talk about new rules for protecting coral reefs and managing shrimp fishing. They want to create a special Rock Shrimp fishing zone near the Oculina Bank to keep habitats safe while supporting fishermen. If you fish or care about ocean habitats in the South Atlantic, these changes could affect you soon!